We were not able to compare our markers’ combinations with other studies since (1) we did not find previous studies in literature using the same markers panel used by our group and (2) there was no study in literature that compared between these three markers, and AFP, for the early detection of HCC (Supplement-3). This evidence concerns the gene AFP and hepatocellular carcinoma.